欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3658/003
药品名称Erlotinib Sandoz 150 mg, film-coated tablets
活性成分
    • erlotinib hydrochloride 150.0 mg
剂型-
上市许可持有人Sandoz B.V. Veluwezoom 22, 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Erlotinib Sandoz 150 mg, film-coated tablets
互认成员国 - 产品名称
    • Italy (IT)
    • Germany (DE)
      Erlotinib - 1 A Pharma 150 mg Filmtabletten
许可日期2017/03/15
最近更新日期2017/03/22
药物ATC编码
    • L01XE03 erlotinib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase